Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014

Overview of attention for article published in Journal of Psychoactive Drugs, March 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Readers on

mendeley: 40 Mendeley

So far, Altmetric has seen 3 policy documents that reference this research output.

Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States: 2015–2020

Cited by Centers for Disease Control and Prevention (CDC) on 28 Apr 2023

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

Linking People with Opioid Use Disorder to Medication Treatment: A Technical Package of Policy, Programs, and Practices

Cited by Centers for Disease Control and Prevention (CDC) on 01 Jan 2022

Evidence-Based Strategies for Preventing Opioid Overdose: What’s Working in the United States: An Introduction for Public Health, Law Enforcement, Local Organizations, and Others Striving to Serve their Community

Cited by Centers for Disease Control and Prevention (CDC) on 27 Sep 2018

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.